Seres Therapeutics, Inc. Business Finance Contracts & Agreements
21 Contracts & Agreements
- Credit Agreements (1 contract)
- Investor Rights Agreements (1)
- Loan Agreements (3)
- Purchase Agreements (3)
- Stock Agreements (6)
- Underwriting Agreements (3)
- Warrant Agreements (4)
- Description of Capital Stock (Filed With SEC on March 5, 2024)
- Credit Agreement and Guaranty, dated April 27, 2023, among Seres Therapeutics, Inc., a Delaware corporation, as the borrower, the subsidiary guarantors from time to time party... (Filed With SEC on April 27, 2023)
- Form of Warrant, dated April 27, 2023, issued by the Company to the Lenders, together with a schedule of warrant holders (Filed With SEC on April 27, 2023)
- Form of Affiliate Purchase Agreement (Filed With SEC on June 30, 2022)
- Form of Non-Affiliate Purchase Agreement (Filed With SEC on June 30, 2022)
- Second Amendment to Loan and Security Agreement, dated February 24, 2022 by and between the Registrant and Hercules Capital, Inc (Filed With SEC on March 1, 2022)
- Description of Capital Stock (Filed With SEC on March 2, 2021)
- Securities Purchase Agreement, dated August 12, 2020, between the Company and Socit des Produits Nestl S.A (Filed With SEC on August 14, 2020)
- Underwriting Agreement, dated August 12, 2020, between the Company and Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters named therein (Filed With SEC on August 14, 2020)
- First Amendment to Loan and Security Agreement by and between the Registrant and Hercules Capital, Inc., dated April 16, 2020 (Filed With SEC on July 28, 2020)
- Description of Capital Stock (Filed With SEC on March 2, 2020)
- Loan and Security Agreement dated October 29, 2019 between Seres Therapeutics, Inc. and Hercules Capital, Inc (Filed With SEC on November 4, 2019)
- Underwriting Agreement, dated June 13, 2019, between the Company and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the several underwriters named... (Filed With SEC on June 14, 2019)
- SERES THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 16, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on June 16, 2015)
- Seres Therapeutics, Inc. Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on June 16, 2015)
- SERIES D PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on May 27, 2015)
- SERES THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 27, 2015)
- Seres Health, Inc. Common Stock Purchase Warrant (Filed With SEC on May 27, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on May 27, 2015)
- AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on May 27, 2015)